Heart Failure
Device
Abbott Laboratories
Total Payments
$6.6M
Transactions
1,255
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $5.8M | 1,063 | 0 |
| 2018 | $748,622 | 192 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.6M | 1,255 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | Abbott Laboratories | $5.8M | 0 |
| Hemodynamic-GUIDEd Management of Heart Failure | Abbott Laboratories | $748,622 | 0 |
Top Doctors Receiving Payments for Heart Failure
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Olympia, WA | $6.6M | 1,255 |
Ad
Manufacturing Companies
- Abbott Laboratories $6.6M
Product Information
- Type Device
- Total Payments $6.6M
- Total Doctors 0
- Transactions 1,255
About Heart Failure
Heart Failure is a device associated with $6.6M in payments to 0 healthcare providers, recorded across 1,255 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2019. In 2019, $5.8M was paid across 1,063 transactions to 0 doctors.
The most common payment nature for Heart Failure is "Unspecified" ($6.6M, 100.0% of total).
Heart Failure is associated with 2 research studies, including "Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF)" ($5.8M).